Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CLINICAL QUESTION: Is transfusing red cell components using a restrictive transfusion threshold (Hb < 75 g L-1 ) as safe as a liberal transfusion threshold (Hb < 95 g L-1 in intensive care and < 85 g L-1 outside intensive care) during and after cardiac surgery for adults at moderate to high risk of death? EVIDENCE FROM TRIAL: In adults undergoing cardiac surgery who were at moderate to high risk for death, using a restrictive red-cell transfusion threshold was as safe as a liberal red cell transfusion threshold (composite outcome of death from any cause, myocardial infarction, stroke or new-onset renal failure with dialysis at 6 months after surgery).

Original publication

DOI

10.1111/tme.12596

Type

Journal article

Journal

Transfus Med

Publication Date

04/2019

Volume

29

Pages

77 - 79

Keywords

cardiac surgery, randomised-controlled trial, red cell transfusions, Aged, Cardiac Surgical Procedures, Critical Care, Erythrocyte Transfusion, Female, Follow-Up Studies, Humans, Male, Middle Aged, Platelet Transfusion